The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma.

MLA

Bernacki, Kurt D., et al. “The Utility of PSMA and PSA Immunohistochemistry in the Cytologic Diagnosis of Metastatic Prostate Carcinoma.” Diagnostic Cytopathology, vol. 42, no. 7, July 2014, pp. 570–75. EBSCOhost, https://doi.org/10.1002/dc.23075.

APA

Bernacki, K. D., Fields, K. L., & Roh, M. H. (2014). The utility of PSMA and PSA immunohistochemistry in the cytologic diagnosis of metastatic prostate carcinoma. Diagnostic Cytopathology, 42(7), 570–575. https://doi.org/10.1002/dc.23075

Chicago

Bernacki, Kurt D, Kristina L Fields, and Michael H Roh. 2014. “The Utility of PSMA and PSA Immunohistochemistry in the Cytologic Diagnosis of Metastatic Prostate Carcinoma.” Diagnostic Cytopathology 42 (7): 570–75. doi:10.1002/dc.23075.